Digital Prevention Platform for Lifelong Health
Official title: Digital Engagement for Lifelong Prevention and Health Improvement
Run by Istituto per la Ricerca e l'Innovazione Biomedica · NCT07612852 · Data updated 2026-11-12
A digital health platform, DELPHI, will test personalized prevention tips for healthy adults aged 18-65 to see if it improves well-being over 12 months.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Istituto per la Ricerca e l'Innovazione Biomedica Academic / other |
| Locations | 1 site (Messina) |
| Status | Recruiting |
| Started | May 4, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | March 30, 2027 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT07612852 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18-65 who own a compatible smartphone and are willing to wear sensors for 12 months.
✕Probably not a fit
Individuals with active severe chronic diseases, unstable conditions, pregnancy, or cognitive/psychiatric impairments may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
DELPHI uses wearable sensors, artificial intelligence, federated learning, and the Human Digital Twin concept to collect and interpret data from healthy adults. In a multicenter randomized pilot, 200 participants will be assigned to receive the full DELPHI platform with personalized recommendations and continuous feedback or to a passive monitoring control for up to 12 months. The study aims to see if this digital approach can support healthier lifestyle choices and prevention of chronic diseases. Data will be analyzed to tailor content and measure changes in health-related behaviors and outcomes. The trial is conducted across sites in Southern Italy with collaboration among research and hospital partners.
Why it matters
Potential benefit: If successful, participants could receive more personalized guidance to adopt healthier lifestyles and reduce future disease risk.
How similar studies have gone: Previous digital health studies have shown promise with personalized digital interventions, though this exact platform represents a novel integration of HDT and federated learning.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Apparent good general health status, confirmed by medical history and initial self-assessment. * Ability to understand the study information and provide informed consent. * Availability and motivation to participate for the entire duration of the study (12 months). * Access to a smartphone compatible with the DELPHI application. * Willingness to wear the wearable devices for continuous monitoring of physiological parameters. * Basic familiarity with mobile applications or willingness to receive training on their use. * Signed informed consent. Exclusion Criteria: * Presence of severe chronic diseases in active phase (e.g., oncological, cardiovascular, or neurological diseases). * Acute or unstable conditions that could compromise participation in the protocol. * Current pregnancy. * Diagnosed major cognitive or psychiatric disorders that hinder understanding of or adherence to the protocol. * Current use of medications that significantly affect the parameters being monitored (e.g., psychotropic drugs, beta-blockers). * Simultaneous participation in other clinical studies. * Logistical difficulties that prevent frequent interaction with the platform (e.g., lack of connection, unwillingness to attend periodic follow-ups).
Where it's running
-
Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)
Messina, Italy Recruiting
Study contacts
- Principal investigator: Gennaro Tartarisco — Institute for Biomedical Research and Innovation (IRIB)-National Reasearch Council (CNR)
- Study coordinator: Gennaro Tartarisco
- Email: gennaro.tartarisco@irib.cnr.it
- Phone: +393283377046
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CARE: Conversations Advancing Resilience and Empowerment
This trial tests a peer-led CARE program to improve quality of life and cardiovascular health in rural and low-income women in Texas.
-
Combined mindfulness and walking-pole program for older adults
This program will try a 4-week mindfulness course followed by 12 weeks of walking-pole exercise to see if it improves physical function, mood, and sleep for community-dwelling adults aged 55 and older.
-
Comparing fruit stands alone versus fruit stands plus an awareness campaign in schools
This project will test whether putting fruit stands in schools, with or without a health-awareness campaign, helps Swedish students aged 7–19 eat more fruit.
-
Dance-Mindfulness program combining Modern Theatre Dance and embodied mindfulness for adult recreational dancers.
This 12-week program tests whether combining Modern Theatre Dance with mindfulness, breath-movement practices, and somatic exercises can reduce stress and improve wellbeing in adults who attend recreational dance classes.
-
Interest in group-based health promotion among migrants and socially vulnerable adults in Nice
We will see if migrant and socially vulnerable adults who use the Médecins du Monde CASO in Nice are interested in group activities to promote health.
-
Health Impact 360: Boosting physical, social, and mental health to prevent heart disease in communities
A community program called Health Impact 360 is being tested to see if it improves heart health and well-being for adults in marginalized neighborhoods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.